TECH - Bio-Techne Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/29/2019
6/29/2018
6/29/2017
6/29/2016
Total Revenue
734,279
714,006
642,993
563,003
499,023
Cost of Revenue
249,977
240,515
210,850
188,462
162,364
Gross Profit
484,302
473,491
432,143
374,541
336,659
Operating Expenses
Research Development
63,701
62,413
55,329
53,514
45,187
Selling General and Administrative
41,667
264,359
240,636
199,243
140,879
Total Operating Expenses
327,737
326,772
295,965
252,757
186,066
Operating Income or Loss
156,565
146,719
136,178
121,784
150,593
Interest Expense
21,688
21,705
10,188
7,361
1,748
Total Other Income/Expenses Net
-23,220
-34,704
-10,226
-8,555
-3,112
Income Before Tax
112,235
112,015
125,952
113,229
147,481
Income Tax Expense
19,168
15,943
602
35,875
43,005
Income from Continuing Operations
93,067
96,072
125,350
77,354
104,476
Net Income
93,067
96,072
125,350
77,286
104,476
Net Income available to common shareholders
92,967
96,072
125,350
77,286
104,476
Reported EPS
Basic
-
2.54
3.36
2.07
2.81
Diluted
-
2.47
3.31
2.06
2.80
Weighted average shares outstanding
Basic
-
37,781
37,476
37,313
37,194
Diluted
-
38,892
38,055
37,500
37,326
EBITDA
-
146,719
136,178
121,784
150,593